Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does RIBOCICLIB Cause Aspartate aminotransferase increased? 745 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 745 reports of Aspartate aminotransferase increased have been filed in association with RIBOCICLIB (KISQALI). This represents 2.7% of all adverse event reports for RIBOCICLIB.

745
Reports of Aspartate aminotransferase increased with RIBOCICLIB
2.7%
of all RIBOCICLIB reports
88
Deaths
209
Hospitalizations

How Dangerous Is Aspartate aminotransferase increased From RIBOCICLIB?

Of the 745 reports, 88 (11.8%) resulted in death, 209 (28.1%) required hospitalization, and 118 (15.8%) were considered life-threatening.

Is Aspartate aminotransferase increased Listed in the Official Label?

Yes, Aspartate aminotransferase increased is listed as a known adverse reaction in the official FDA drug label for RIBOCICLIB.

What Other Side Effects Does RIBOCICLIB Cause?

Neutropenia (3,585) Nausea (3,404) Fatigue (3,327) Malignant neoplasm progression (2,468) Death (2,452) Vomiting (1,953) Diarrhoea (1,830) White blood cell count decreased (1,683) Pain (1,637) Metastases to bone (1,538)

What Other Drugs Cause Aspartate aminotransferase increased?

METHOTREXATE (1,600) RITUXIMAB (1,351) ADALIMUMAB (1,166) TOCILIZUMAB (975) ETANERCEPT (939) ACETAMINOPHEN (865) LEFLUNOMIDE (863) INFLIXIMAB (823) ABATACEPT (778) NIVOLUMAB (758)

Which RIBOCICLIB Alternatives Have Lower Aspartate aminotransferase increased Risk?

RIBOCICLIB vs RIBOFLAVIN RIBOCICLIB vs RIBOFLAVIN 5'-PHOSPHATE RIBOCICLIB vs RIBOFLAVIN 5^-PHOSPHATE RIBOCICLIB vs RIFABUTIN RIBOCICLIB vs RIFAMPICIN

Related Pages

RIBOCICLIB Full Profile All Aspartate aminotransferase increased Reports All Drugs Causing Aspartate aminotransferase increased RIBOCICLIB Demographics